Upregulation of adenosine receptors in the frontal cortex in Alzheimer's disease, Brain Pathol, vol.18, pp.211-219, 2008. ,
Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology, Brain Pathol, 2018. ,
Immunity, inflammation and cancer: a leading role for adenosine, Nat. Rev. Cancer, vol.13, pp.842-857, 2013. ,
Caffeine reverses cognitive impairment and decreases brain amyloidbeta levels in aged Alzheimer's disease mice, J. Alzheimers Dis, vol.17, pp.661-680, 2009. ,
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production, Neuroscience, vol.142, pp.941-952, 2006. ,
Long-term treatment with low-dose caffeine worsens BPSD-like profile in 3xTg-AD mice model of Alzheimer's disease and affects mice with normal aging, Front. Pharmacol, vol.9, p.79, 2018. ,
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function, Sci. Rep, vol.6, p.31493, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01833352
Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation, Mol. Psychiatry, vol.18, pp.320-331, 2013. ,
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics, Lancet Neurol, vol.2, pp.366-374, 2003. ,
Adenosinergic signaling in epilepsy, Neuropharmacology, vol.104, pp.131-139, 2016. ,
Adenosine as a multisignalling guardian angel in human diseases: When, where and how does it exert its protective effects?, Trends Pharmacol. Sci, vol.37, pp.419-434, 2016. ,
Post-study caffeine administration enhances memory consolidation in humans, Nat. Neurosci, vol.17, pp.201-203, 2014. ,
Adenosine mediation of presynaptic feedback inhibition of glutamate release, Neuron, vol.46, pp.275-283, 2005. ,
Tau and A? imaging, CSF measures, and cognition in Alzheimer's disease, Sci. Transl. Med, vol.8, pp.338-66, 2016. ,
The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus, Neuropharmacology, vol.36, pp.1201-1210, 1997. ,
Purine and pyrimidine receptors, Cell. Mol. Life Sci, vol.64, pp.1471-1483, 2007. ,
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway, J. Neurosci, vol.29, pp.14741-14751, 2009. ,
Adenosine receptor control of cognition in normal and disease, Int. Rev. Neurobiol, vol.119, pp.257-307, 2014. ,
Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission, J. Neurosci, vol.34, pp.11228-11232, 2014. ,
Case series of mild behavioral impairment: toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition, Int. Psychogeriatr, vol.30, pp.273-280, 2018. ,
Role of adenosine in oligodendrocyte precursor maturation, Front. Cell. Neurosci, vol.9, p.155, 2015. ,
, , 2013.
, Adenosine A 2 A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures, Neuropharmacology, vol.73, pp.301-310
A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes, Purinergic Signal, vol.9, pp.433-449, 2013. ,
Adenosine A2A receptor blockade prevents memory dysfunction caused by ?-amyloid peptides but not by scopolamine or MK-801, Exp. Neurol, vol.210, pp.776-781, 2008. ,
How does adenosine control neuronal dysfunction and neurodegeneration?, J. Neurochem, vol.139, pp.1019-1055, 2016. ,
Caffeine and adenosine A(2a) receptor antagonists prevent betaamyloid (25-35)-induced cognitive deficits in mice, Exp. Neurol, vol.203, pp.241-245, 2007. ,
Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity, Br. J. Pharmacol, vol.138, pp.1207-1209, 2003. ,
Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology, Brain, vol.140, p.39, 2017. ,
Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process, Physiol. Rev, vol.90, pp.465-494, 2010. ,
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau K280, Proc. Natl. Acad. Sci. U.S.A, vol.113, pp.11597-11602, 2016. ,
Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk, Mol. Neurodegener, vol.12, p.43, 2017. ,
Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study, J. Alzheimers Dis, vol.16, pp.85-91, 2009. ,
Beneficial effect of a selective adenosine A 2A receptor antagonist in the APPswe/PS1de9 mouse model of Alzheimer's Disease, Front. Mol. Neurosci, vol.10, p.14, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01930489
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial, Lancet Neurol, vol.15, pp.336-337, 2016. ,
Neurotrophic factors in Parkinson's disease: What have we learned from pre-clinical and clinical studies?, Curr. Med. Chem, 2018. ,
Caffeine as a psychomotor stimulant: mechanism of action, Cell. Mol. Life Sci, vol.61, pp.857-872, 2004. ,
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?, Biochem. Soc. Trans, vol.42, pp.587-592, 2014. ,
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev, vol.51, pp.83-133, 1999. ,
Adenosine and brain function, Int. Rev. Neurobiol, vol.63, pp.63007-63010, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02185490
, , 2011.
, Coffee intake in midlife and risk of dementia and its neuropathologic correlates, J. Alzheimers Dis, vol.23, pp.607-615
Different danger signals differently impact on microglial proliferation through alterations of ATP release and extracellular metabolism, Glia, vol.63, pp.1636-1645, 2015. ,
Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain, Neurobiol. Learn. Mem, vol.87, pp.42-56, 2007. ,
Brain metabolism dictates the polarity of astrocyte control over arterioles, Nature, vol.456, pp.745-749, 2008. ,
Cognitive and mood improvements of caffeine in habitual consumers and habitual nonconsumers of caffeine, Psychopharmacology, vol.179, pp.813-825, 2005. ,
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial, Lancet Neurol, vol.13, issue.14, pp.70148-70154, 2014. ,
Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease, Neurobiol. Aging, vol.60, pp.92-103, 2017. ,
Roles of adenosine and its receptors in sleep-wake regulation, Int. Rev. Neurobiol, vol.119, pp.349-371, 2014. ,
Human cytosolic 5'-nucleotidase I: characterization and role in nucleoside analog resistance, J. Biol. Chem, vol.276, pp.10498-10504, 2001. ,
Adenosine release during seizures attenuates GABAA receptor-mediated depolarization, J. Neurosci, vol.32, pp.5321-5332, 2012. ,
Microglia release ATP by exocytosis, Glia, vol.61, pp.1320-1330, 2013. ,
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration, Cell Death Dis, vol.9, p.120, 2018. ,
Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP, Neuropharmacology, vol.83, pp.99-106, 2014. ,
ATP release through lysosomal exocytosis from peripheral nerves: the effect of lysosomal exocytosis on peripheral nerve degeneration and regeneration after nerve injury, Biomed Res. Int, p.936891, 2014. ,
Possible ATP release through lysosomal exocytosis from primary sensory neurons, Biochem. Biophys. Res. Commun, vol.430, pp.488-493, 2013. ,
Adenosine A2A receptor gene disruption protects in an ?-synuclein model of Parkinson's disease, Ann. Neurol, vol.71, pp.278-282, 2012. ,
Caffeine controls glutamatergic synaptic transmission and pyramidal neuron excitability in human neocortex, Front. Pharmacol, vol.8, p.899, 2017. ,
A2A adenosine receptor regulates the human blood-brain barrier permeability, Mol. Neurobiol, vol.52, pp.664-678, 2015. ,
Nucleoside transporters: from scavengers to novel therapeutic targets, Trends Pharmacol. Sci, vol.27, pp.416-425, 2006. ,
Adenosine in the central nervous system: release mechanisms and extracellular concentrations, J. Neurochem, vol.79, pp.463-484, 2001. ,
Tau and neuroinflammation: What impact for Alzheimer's disease and tauopathies?, Biomed. J, vol.41, pp.21-33, 2018. ,
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy, Mol. Psychiatry, vol.21, pp.97-107, 2016. ,
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology, Neurobiol. Aging, vol.35, pp.2079-2090, 2014. ,
Adenosine augmentation evoked by an ENT1 inhibitor improves memory impairment and neuronal plasticity in the APP/PS1 mouse model of Alzheimer's disease, Mol. Neurobiol, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01833298
Glial contributions to neurodegeneration in tauopathies, Mol. Neurodegener, vol.12, p.50, 2017. ,
Caffeine, through adenosine A3 receptor-mediated actions, suppresses amyloid-? protein precursor internalization and amyloid-? generation, J. Alzheimers Dis, vol.47, pp.73-83, 2015. ,
Regulation of lymphocyte function by adenosine, Arterioscler. Thromb. Vasc. Biol, vol.32, pp.2097-2103, 2012. ,
Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway, Immun. Inflamm. Dis, vol.6, pp.72-80, 2018. ,
Dementia prevention, intervention, and care, Lancet, vol.390, issue.17, pp.31363-31369, 2017. ,
Pannexin-1-mediated ATP release from area CA3 drives mGlu5-dependent neuronal oscillations, Neuropharmacology, vol.93, pp.219-228, 2015. ,
Caffeine, fatigue, and cognition, Brain Cogn, vol.53, pp.82-94, 2003. ,
An anti-Parkinson's disease drug via targeting adenosine A2A receptor enhances amyloid-? generation and ?-secretase activity, PLoS One, vol.11, 2016. ,
Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury, Transl. Res, vol.169, pp.112-128, 2016. ,
Does caffeine intake protect from Alzheimer's disease?, Eur. J. Neurol, vol.9, pp.377-382, 2002. ,
Antagonistic interaction between adenosine A2A receptors and Na + /K + -ATPase-?2 controlling glutamate uptake in astrocytes, J. Neurosci, vol.33, pp.18492-18502, 2013. ,
Astrocytic adenosine A2A receptors control the amyloid-? peptide-induced decrease of glutamate uptake, J. Alzheimers Dis, vol.31, pp.555-567, 2012. ,
Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes, Glia, vol.60, pp.702-716, 2012. ,
Neural and humoral control of regional vascular beds via A1 adenosine receptors located in the nucleus tractus solitarii, Am. J. Physiol. Regul. Integr. Comp. Physiol, vol.300, 2011. ,
Striatal outflow of adenosine, excitatory amino acids, gammaaminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage, Stroke, vol.30, pp.2448-2454, 1999. ,
The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS, Brain Sci, vol.6, p.6, 2016. ,
Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study, Sleep, vol.26, pp.943-947, 2003. ,
Hydrogen sulfide inhibits A2A adenosine receptor agonist induced ?-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway, PLoS One, vol.9, p.88508, 2014. ,
Interindividual differences in caffeine metabolism and factors driving caffeine consumption, Pharmacol. Rev, vol.70, pp.384-411, 2018. ,
2' ,3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-? and CXCL10 production from activated primary murine microglia via A2A receptors, Brain Res, vol.1594, pp.27-35, 2015. ,
Current and experimental treatments of Parkinson disease: a guide for neuroscientists, J. Neurochem, vol.139, pp.325-337, 2016. ,
Physiological functions of glial cell hemichannels, Adv. Exp. Med. Biol, vol.949, pp.93-108, 2016. ,
Restraint stress increases hemichannel activity in hippocampal glial cells and neurons. Front, Cell. Neurosci, vol.9, p.102, 2015. ,
Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory, Nat. Neurosci, vol.18, pp.423-434, 2015. ,
Istradefylline reduces memory deficits in aging mice with amyloid pathology, Neurobiol. Dis, vol.110, pp.29-36, 2018. ,
Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice, Br. J. Pharmacol, vol.172, pp.3831-3845, 2015. ,
Molecular biology of nucleoside transporters and their distributions and functions in the brain, Curr. Top. Med. Chem, vol.11, pp.948-972, 2011. ,
Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat, Neurobiol. Learn. Mem, vol.83, pp.217-223, 2005. ,
Adenosine, energy metabolism and sleep homeostasis, Sleep Med. Rev, vol.15, pp.123-135, 2011. ,
Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness, Science, vol.276, pp.1265-1268, 1997. ,
Caffeine protects against oxidative stress and Alzheimer's diseaselike pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic, Biol. Med, vol.49, 2010. ,
Epigenetics in Alzheimer's disease: perspective of DNA methylation, Mol. Neurobiol, vol.55, pp.1026-1044, 2018. ,
Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses, Neuron, vol.57, pp.121-134, 2008. ,
Epidemiology of Alzheimer disease, Nat. Rev. Neurol, vol.7, pp.137-152, 2011. ,
The neuroprotective effects of caffeine: a prospective population study (the Three City Study), Neurology, vol.69, pp.536-545, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00168786
Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex, Brain Res, vol.692, pp.227-232, 1995. ,
DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease, Brain, vol.136, pp.3018-3027, 2013. ,
Caffeine intake and dementia: systematic review and meta-analysis, J. Alzheimers Dis, vol.20, pp.187-204, 2010. ,
Caffeine and human behavior: arousal, anxiety, and performance effects, J. Behav. Med, vol.5, pp.415-439, 1982. ,
Alzheimer's disease, Lancet, vol.388, pp.505-517, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01723790
Action of caffeine as an amyloid inhibitor in the aggregation of A?16-22 peptides, J. Phys. Chem. B, vol.120, pp.9019-9033, 2016. ,
Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease, Neurobiol. Dis, vol.350, pp.99-108, 2018. ,
Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers, Psychopharmacology, vol.152, pp.167-173, 2000. ,
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors, Mol. Psychiatry, 2018. ,
Does caffeine consumption modify cerebrospinal fluid amyloid? levels in patients with Alzheimer's disease?, J. Alzheimers Dis, vol.47, pp.1069-1078, 2015. ,
Early synaptic deficits in the APP/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors, Nat. Commun, vol.7, p.11915, 2016. ,
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis, J. Clin. Invest, vol.123, pp.3552-3563, 2013. ,
Increased cerebrospinal fluid production as a possible mechanism underlying caffeine's protective effect against Alzheimer's disease, Int. J. Alzheimers Dis, p.617420, 2011. ,
Signalling via ATP in the nervous system, Trends Neurosci, vol.17, pp.420-426, 1994. ,
Extracellular metabolism of ATP and other nucleotides, Naunyn Schmiedebergs Arch. Pharmacol, vol.362, pp.299-309, 2000. ,
Nucleotide signaling in nervous system development, Pflugers Arch, vol.452, pp.573-588, 2006. ,
Cellular function and molecular structure of ecto-nucleotidases, Purinergic Signal, vol.8, pp.437-502, 2012. ,
Modulation of intracellular ATP determines adenosine release and functional outcome in response to metabolic stress in rat hippocampal slices and cerebellar granule cells, J. Neurochem, vol.128, pp.111-124, 2014. ,